|
|
Suppliers for
Lopinavir
|
Properties | CAS |
192725-17-0 | Formula |
C37H48N4O5 |
|
|
22 Registered suppliers
More details are to be found here
More details are to be found here
More details are to be found here
More details are to be found here
More details are to be found here
More details are to be found here
Molecular Formula: C37H48N4O5 Molecular Weight: 628.80
More details are to be found here
Molecular Formula: C37H48N4O5 Molecular Weight: 628.80
More details are to be found here
Molecular Formula: C37H48N4O5 Molecular Weight: 628.80
More details are to be found here
Molecular Formula: C37H48N4O5 Molecular Weight: 628.80
More details are to be found here
Molecular Formula: C37H48N4O5 Molecular Weight: 628.80
More details are to be found here
Molecular Formula: C37H48N4O5 Molecular Weight: 628.80
More details are to be found here
More details are to be found here
More details are to be found here
Description : An antiretroviral medication acts as a protease inhibitor. It is a co-formulation with a sub-therapeutic dose of ritonavir, as a component of combination therapy to treat HIV/AIDS. - Molecular Weight :628.81
- Boiling Point :924.2±65.0 °C at 760 mmHg
- Melting Point :95-98°C
- Purity :≥98%
Molecular Formula : C37H48N4O5 Canonical SMILES : CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O InChI : InChI=1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1 InChIKey : KJHKTHWMRKYKJE-SUGCFTRWSA-N Solubility : In Vitro: DMSO: 100 mg/mL (159.03 mM; Need ultrasonic) In Vivo: 1.Add each solvent one by one: 10% DMSO > > 40% PEG300 > > 5% Tween-80 > > 45% saline Solubility: ≥ 2.5 mg/mL (3.98 mM); Clear solution 2.Add each solvent one by one: 10% DMSO > > 90% corn oil Solubility: ≥ 2.5 mg/mL (3.98 mM); Clear solution Appearance : White Solid Storage : Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month Synonyms : ABT 378; ABT-378; ABT378; Aluviran; Kaletra
More details are to be found here
Description : An antiretroviral medication acts as a protease inhibitor. It is a co-formulation with a sub-therapeutic dose of ritonavir, as a component of combination therapy to treat HIV/AIDS. - Molecular Weight :628.81
- Boiling Point :924.2±65.0 °C at 760 mmHg
- Melting Point :95-98°C
- Purity :≥98%
Molecular Formula : C37H48N4O5 Canonical SMILES : CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O InChI : InChI=1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1 InChIKey : KJHKTHWMRKYKJE-SUGCFTRWSA-N Solubility : In Vitro: DMSO: 100 mg/mL (159.03 mM; Need ultrasonic) In Vivo: 1.Add each solvent one by one: 10% DMSO > > 40% PEG300 > > 5% Tween-80 > > 45% saline Solubility: ≥ 2.5 mg/mL (3.98 mM); Clear solution 2.Add each solvent one by one: 10% DMSO > > 90% corn oil Solubility: ≥ 2.5 mg/mL (3.98 mM); Clear solution Appearance : White Solid Storage : Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month Synonyms : ABT 378; ABT-378; ABT378; Aluviran; Kaletra
More details are to be found here
Description : An antiretroviral medication acts as a protease inhibitor. It is a co-formulation with a sub-therapeutic dose of ritonavir, as a component of combination therapy to treat HIV/AIDS. - Molecular Weight :628.81
- Boiling Point :924.2±65.0 °C at 760 mmHg
- Melting Point :95-98°C
- Purity :≥98%
Molecular Formula : C37H48N4O5 Canonical SMILES : CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O InChI : InChI=1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1 InChIKey : KJHKTHWMRKYKJE-SUGCFTRWSA-N Solubility : In Vitro: DMSO: 100 mg/mL (159.03 mM; Need ultrasonic) In Vivo: 1.Add each solvent one by one: 10% DMSO > > 40% PEG300 > > 5% Tween-80 > > 45% saline Solubility: ≥ 2.5 mg/mL (3.98 mM); Clear solution 2.Add each solvent one by one: 10% DMSO > > 90% corn oil Solubility: ≥ 2.5 mg/mL (3.98 mM); Clear solution Appearance : White Solid Storage : Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month Synonyms : ABT 378; ABT-378; ABT378; Aluviran; Kaletra
More details are to be found here
Description : An antiretroviral medication acts as a protease inhibitor. It is a co-formulation with a sub-therapeutic dose of ritonavir, as a component of combination therapy to treat HIV/AIDS. - Molecular Weight :628.81
- Boiling Point :924.2±65.0 °C at 760 mmHg
- Melting Point :95-98°C
- Purity :≥98%
Molecular Formula : C37H48N4O5 Canonical SMILES : CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O InChI : InChI=1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1 InChIKey : KJHKTHWMRKYKJE-SUGCFTRWSA-N Solubility : In Vitro: DMSO: 100 mg/mL (159.03 mM; Need ultrasonic) In Vivo: 1.Add each solvent one by one: 10% DMSO > > 40% PEG300 > > 5% Tween-80 > > 45% saline Solubility: ≥ 2.5 mg/mL (3.98 mM); Clear solution 2.Add each solvent one by one: 10% DMSO > > 90% corn oil Solubility: ≥ 2.5 mg/mL (3.98 mM); Clear solution Appearance : White Solid Storage : Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month Synonyms : ABT 378; ABT-378; ABT378; Aluviran; Kaletra
More details are to be found here
Description : An antiretroviral medication acts as a protease inhibitor. It is a co-formulation with a sub-therapeutic dose of ritonavir, as a component of combination therapy to treat HIV/AIDS. - Molecular Weight :628.81
- Boiling Point :924.2±65.0 °C at 760 mmHg
- Melting Point :95-98°C
- Purity :≥98%
Molecular Formula : C37H48N4O5 Canonical SMILES : CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O InChI : InChI=1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1 InChIKey : KJHKTHWMRKYKJE-SUGCFTRWSA-N Solubility : In Vitro: DMSO: 100 mg/mL (159.03 mM; Need ultrasonic) In Vivo: 1.Add each solvent one by one: 10% DMSO > > 40% PEG300 > > 5% Tween-80 > > 45% saline Solubility: ≥ 2.5 mg/mL (3.98 mM); Clear solution 2.Add each solvent one by one: 10% DMSO > > 90% corn oil Solubility: ≥ 2.5 mg/mL (3.98 mM); Clear solution Appearance : White Solid Storage : Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month Synonyms : ABT 378; ABT-378; ABT378; Aluviran; Kaletra
More details are to be found here
Description : An antiretroviral medication acts as a protease inhibitor. It is a co-formulation with a sub-therapeutic dose of ritonavir, as a component of combination therapy to treat HIV/AIDS. - Molecular Weight :628.81
- Boiling Point :924.2±65.0 °C at 760 mmHg
- Melting Point :95-98°C
- Purity :≥98%
Molecular Formula : C37H48N4O5 Canonical SMILES : CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O InChI : InChI=1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1 InChIKey : KJHKTHWMRKYKJE-SUGCFTRWSA-N Solubility : In Vitro: DMSO: 100 mg/mL (159.03 mM; Need ultrasonic) In Vivo: 1.Add each solvent one by one: 10% DMSO > > 40% PEG300 > > 5% Tween-80 > > 45% saline Solubility: ≥ 2.5 mg/mL (3.98 mM); Clear solution 2.Add each solvent one by one: 10% DMSO > > 90% corn oil Solubility: ≥ 2.5 mg/mL (3.98 mM); Clear solution Appearance : White Solid Storage : Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month Synonyms : ABT 378; ABT-378; ABT378; Aluviran; Kaletra
More details are to be found here
Description : An antiretroviral medication acts as a protease inhibitor. It is a co-formulation with a sub-therapeutic dose of ritonavir, as a component of combination therapy to treat HIV/AIDS. - Molecular Weight :628.81
- Boiling Point :924.2±65.0 °C at 760 mmHg
- Melting Point :95-98°C
- Purity :≥98%
Molecular Formula : C37H48N4O5 Canonical SMILES : CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O InChI : InChI=1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1 InChIKey : KJHKTHWMRKYKJE-SUGCFTRWSA-N Solubility : In Vitro: DMSO: 100 mg/mL (159.03 mM; Need ultrasonic) In Vivo: 1.Add each solvent one by one: 10% DMSO > > 40% PEG300 > > 5% Tween-80 > > 45% saline Solubility: ≥ 2.5 mg/mL (3.98 mM); Clear solution 2.Add each solvent one by one: 10% DMSO > > 90% corn oil Solubility: ≥ 2.5 mg/mL (3.98 mM); Clear solution Appearance : White Solid Storage : Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month Synonyms : ABT 378; ABT-378; ABT378; Aluviran; Kaletra
More details are to be found here
Description : An antiretroviral medication acts as a protease inhibitor. It is a co-formulation with a sub-therapeutic dose of ritonavir, as a component of combination therapy to treat HIV/AIDS. - Molecular Weight :628.81
- Boiling Point :924.2±65.0 °C at 760 mmHg
- Melting Point :95-98°C
- Purity :≥98%
Molecular Formula : C37H48N4O5 Canonical SMILES : CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O InChI : InChI=1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1 InChIKey : KJHKTHWMRKYKJE-SUGCFTRWSA-N Solubility : In Vitro: DMSO: 100 mg/mL (159.03 mM; Need ultrasonic) In Vivo: 1.Add each solvent one by one: 10% DMSO > > 40% PEG300 > > 5% Tween-80 > > 45% saline Solubility: ≥ 2.5 mg/mL (3.98 mM); Clear solution 2.Add each solvent one by one: 10% DMSO > > 90% corn oil Solubility: ≥ 2.5 mg/mL (3.98 mM); Clear solution Appearance : White Solid Storage : Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month Synonyms : ABT 378; ABT-378; ABT378; Aluviran; Kaletra
More details are to be found here
Detailed information on the suppliers of
Lopinavir
|
Properties:
... more properties and specification on Lopinavir
|
|
Privileged suppliers
Last update 2024-04-26
|